REAL LIFE EGYPTIAN EXPERIENCE OF COMBINATION THERAPY (SIMEPREVIR/SOFOSBUVIR) IN EXPERIENCED NON CIRRHOTIC HCV PATIENTS
Background Egypt has the highest prevalent in presence of chronic HCV infection that may lead to cirrhosis, portal hypertension, hepatocellular failure and hepatocellular carcinoma. Developing of new drugs in HCV treatment has been developed using direct acting antiviral activity. In this study we...
Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Al-Azhar University, Faculty of Pharmacy
2017-03-01
|
| Series: | Al-Azhar Journal of Pharmaceutical Sciences |
| Assuntos: | |
| Acceso en liña: | https://ajps.journals.ekb.eg/article_28414_393e2d63f782f65f014e369b4488fec5.pdf |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|